Comments

Arcus Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Arcus Biosciences (RCUS) operate in?

Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

RCUSNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$9.58

-0.44-4.39%

At close: -

$9.58

0.000.00%

After Hours: Mar 7, 4:00 PM EDT

Arcus Biosciences (RCUS) Forecast

News Earnings Arcus Biosciences (RCUS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Arcus Biosciences Stock Price, Quotes and Forecasts | NYSE:RCUS | Benzinga

Explore Arcus Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RCUS.

Open	$9.93
Close	$9.58
Volume / Avg.	885.71K / 880.21K
Day Range	$9.50 - $10.00
52 Wk Range	9.42 - 19.69
Market Cap	$1.01B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	34
Short Interest	11.02%
Days to Cover	10.94

Recent News

Arcus Biosciences Shares Are Down Today: What's Going On?

Arcus Biosciences Inc. (NYSE: RCUS) shares are trading lower Tuesday after the company announced a $150 million common stock offering.

Vaishali Prayag

Ericsson Posts Weak Results, Joins East West Bancorp And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Avi Kapoor

This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$9.93
Close	$9.58
Volume / Avg.	885.71K / 880.21K
Day Range	$9.50 - $10.00
52 Wk Range	9.42 - 19.69
Market Cap	$1.01B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	34
Short Interest	11.02%
Days to Cover	10.94

About Arcus Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Arcus Biosciences (RCUS) stock?

You can purchase shares of Arcus Biosciences (NYSE:RCUS) through any online brokerage.

View our list of the best stock brokerages

Who are Arcus Biosciences (RCUS) competitors?

Other companies in Arcus Biosciences’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for Arcus Biosciences (RCUS) stock?

Arcus Biosciences has a consensus price target of $35.69.

What is the current price for Arcus Biosciences (RCUS)?

The stock price for Arcus Biosciences (NYSE: RCUS) is $9.58 last updated March 7, 2025 at 4:00 PM EST.

Does Arcus Biosciences (RCUS) pay a dividend?

There are no upcoming dividends for Arcus Biosciences.

When is Arcus Biosciences (NYSE:RCUS) reporting earnings?

Arcus Biosciences’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Arcus Biosciences (RCUS) going to split?

There is no upcoming split for Arcus Biosciences.

What sector and industry does Arcus Biosciences (RCUS) operate in?

Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.